Table 2. Patients who received botulinum toxin injection for their first intervention (n=28).
SLE, sublingual excision; DL, duct ligation; SMG, submandibular gland; PG, parotid gland; SMGE, submandibular gland excision; SMD, submandibular duct.
| Botulinum toxin injection for the first intervention | n (%) |
| 1 botulinum toxin injection | 9 (32%) |
| 2 botulinum toxin injections | 4 (14%) |
| 1 botulinum toxin injection followed by surgical intervention | |
| SLE DL | 3 (11%) |
| SMG and PG ligation | 2 (7%) |
| SMGE | 1 (4%) |
| SLE and SMG neurectomy | 1 (4%) |
| 1 botulinum toxin injection followed by 2 surgical interventions | |
| SLE DL then SMGE | 1 (4%) |
| 2 botulinum toxin injections followed by surgical intervention | |
| SLE DL | 3 (11%) |
| SLE and SMD rerouting | 1 (4%) |
| 3 botulinum toxin injections followed by surgical intervention | |
| SMG and SMD ligation | 1 (4%) |
| Tracheostomy | 1 (4%) |
| 4 botulinum toxin injections | 1 (4%) |